| 926 |
Centers for Disease Control and Prevention |
Html |
en |
H7N9 Case Detected in Malaysia |
H7N9 Case Detected in Malaysia - CDC |
| risk assessment | 0.786511 |
| CVV | 0.445898 |
| avian influenza | 0.563111 |
| CDC | 0.487944 |
| poultry exposure | 0.655622 |
| traveler | 0.608129 |
| evidence | 0.452534 |
| United States | 0.539506 |
| human cases | 0.631417 |
| birds | 0.426311 |
| H7N9 case | 0.547669 |
| H7N9 vaccine | 0.541132 |
| global outbreak | 0.52803 |
| human-to-human spread | 0.572803 |
| neighboring countries | 0.524943 |
| international partners | 0.518391 |
| international surveillance | 0.647656 |
| scenario | 0.425549 |
| China | 0.760647 |
| continue | 0.42441 |
| infected poultry | 0.558357 |
| U.S. Government | 0.530856 |
| new H7N9 virus | 0.886318 |
| H7N9 situation | 0.537505 |
|
| clinical trials | 0.5278 |
| public health risk | 0.629054 |
| candidate vaccine virus | 0.668325 |
| event | 0.424029 |
| routine preparedness actions | 0.632446 |
| area | 0.426085 |
| detection | 0.452809 |
| suitability | 0.426514 |
| contaminated environments | 0.542127 |
| people | 0.452743 |
| limited amounts | 0.529473 |
| symptoms | 0.42906 |
| human infections | 0.651184 |
| new virus | 0.558608 |
| influenza viruses | 0.666796 |
| transmissibility | 0.425117 |
| important factor | 0.532534 |
| pandemic potential | 0.785168 |
| ongoing person-to-person spread | 0.909229 |
| H7N9 | 0.887027 |
| Malaysian Ministry | 0.555623 |
| time | 0.481127 |
| threat | 0.425133 |
|
CLICK HERE |
| 4425 |
Centers for Disease Control and Prevention |
Html |
en |
Diseases & Conditions A-Z Index - N |
CDC Diseases and Conditions A-Z Index |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 5517 |
Centers for Disease Control and Prevention |
Html |
en |
Propane - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 9367 |
Centers for Disease Control and Prevention |
Html |
es |
Marco de trabajo para la diseminación de prácticas de promoción de la salud basadas en la evidencia |
CDC - Wide Page example description goes here |
| Cancer Society Workplace | 0.985922 |
|
|
CLICK HERE |
| 9570 |
Centers for Disease Control and Prevention |
Html |
en |
Announcements: National Fall Prevention Awareness Day -September 22, 2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.529335 |
| fall injuries | 0.525091 |
| age group increases | 0.610523 |
| original MMWR paper | 0.60307 |
| U.S. Government Printing | 0.599566 |
| tool kit | 0.510718 |
| Human Services | 0.581944 |
| assistive technology | 0.527191 |
| health-care providers | 0.513361 |
| elderly nursing home | 0.605627 |
| older persons | 0.531986 |
| MMWR HTML versions | 0.595418 |
| U.S. Department | 0.58054 |
| MMWR readers | 0.510877 |
| O'Connor JA | 0.517155 |
| reduced mobility | 0.514516 |
| electronic PDF version | 0.595161 |
| 10,000 women | 0.516973 |
| National Fall Prevention | 0.620419 |
| hip fracture rates | 0.852707 |
| Bonadies J. Geriatric | 0.597778 |
| total number | 0.51542 |
| home safety improvements | 0.604784 |
| information resources | 0.519668 |
|
| U.S. population ages | 0.61775 |
| older patients | 0.51328 |
| hip fractures | 0.917229 |
| Pluijm SMF | 0.513771 |
| subject line | 0.526554 |
| Additional information | 0.521563 |
| Contact GPO | 0.522193 |
| Clin Epidemiol | 0.518062 |
| fall risk | 0.521219 |
| fracture risk | 0.528096 |
| online resource | 0.510332 |
| eye doctor | 0.513363 |
| Hayes WC | 0.50904 |
| Calcif Tissue Int | 0.591633 |
| injury severity | 0.509684 |
| Fall-risk screening test | 0.594314 |
| pharmacist review | 0.51482 |
| original paper copy | 0.589232 |
| et al | 0.607665 |
| older adults | 0.517608 |
| Smit JH | 0.517901 |
| Stevens JA | 0.512 |
| adequate calcium | 0.511633 |
|
CLICK HERE |
| 9658 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH A-Z Index - H |
null |
| MPEG | 0.502478 |
| site | 0.37094 |
| PDF | 0.374179 |
| PPT | 0.576414 |
|
| email address | 0.737981 |
| DOC | 0.493605 |
| different file formats | 0.947299 |
|
CLICK HERE |
| 10079 |
Centers for Disease Control and Prevention |
Html |
es |
Espina bífida, Problemas de salud y tratamientos - NCBDDD |
Spina bifida is a condition that affects the spine and is usually apparent at birth. It is a type of neural tube defect (NTD). |
| Archivo Apple Quicktime | 0.614332 |
| Archivo RealPlayer | 0.537227 |
| Archivo Microsoft PowerPoint | 0.635381 |
| Archivo Adobe PDF | 0.613582 |
| Archivo Microsoft | 0.977991 |
| Archivo Microsoft Word | 0.632526 |
| Intervención Temprana | 0.541606 |
| protector solar | 0.529776 |
|
| personas con discapacidades | 0.90031 |
| Archivo Zip Comprimido | 0.611993 |
| New England Journal | 0.66598 |
| Archivo Microsoft Excel | 0.615215 |
| médula espinal flota | 0.838568 |
| pequeño tubo | 0.549701 |
| Edad Preescolar | 0.534261 |
| National Institutes | 0.56206 |
|
CLICK HERE |
| 12120 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance for U.S. Hospital Preparedness for Patients with Possible or Confirmed Ebola Virus Disease: A Framework for aTiered Approach | Ebola Hemorrhagic Fever |
null |
| ebola treatment center | 0.984043 |
| EVD diagnosis | 0.381891 |
| Ebola treament center | 0.444211 |
| public health authorities | 0.521094 |
| hospital/facility infection control | 0.389001 |
| infection control program | 0.388996 |
| state | 0.451589 |
| urgent care clinics | 0.448353 |
| personal protective equipment | 0.389341 |
| patients | 0.453001 |
| Potential Ebola Virus | 0.450593 |
| PUIs | 0.376879 |
| ebola virus disease | 0.634819 |
| healthcare facilities | 0.655097 |
| Ebola hospital preparedness | 0.46109 |
| EVD | 0.561553 |
| acute healthcare facilities | 0.395695 |
| CDC Ebola Response | 0.438758 |
| frontline healthcare facility | 0.450626 |
| emergency care settings | 0.440938 |
| Ebola patients | 0.43783 |
| acute care hospitals | 0.411078 |
| public health agencies | 0.395818 |
| Ebola preparedness | 0.444658 |
| clinically stable persons | 0.387442 |
|
| acute care facilities | 0.369693 |
| Ebola assessment hospital | 0.607684 |
| PPE | 0.441936 |
| Emergency Department Evaluation | 0.442975 |
| infection control | 0.424648 |
| ambulatory care settings | 0.40833 |
| frontline healthcare facilities | 0.634997 |
| PPE guidance | 0.376942 |
| local health | 0.430313 |
| local health departments | 0.428985 |
| public health | 0.578819 |
| Ebola assessment hospitals | 0.88426 |
| Ebola treatment centers | 0.677909 |
| non-emergent ambulatory care | 0.368435 |
| additional PPE supplies | 0.37396 |
| primary care offices | 0.410539 |
| local public health | 0.482774 |
| relevant exposure | 0.368882 |
| urgent/emergency care settings | 0.367056 |
| confirmed EVD | 0.367675 |
| widespread Ebola transmission | 0.435449 |
| Ebola testing | 0.479108 |
| guidance | 0.377617 |
| current PPE shortages | 0.375507 |
|
CLICK HERE |
| 13741 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Severe Illness Associated withReported Use of Synthetic Cannabinoids - Mississippi, April2015 |
Amelia M. Kasper, MD1,2; Alison D. Ridpath, MD2; Justin K. |
| 1Epidemic Intelligence Service | 0.531269 |
| electronic medical records | 0.562031 |
| 7Mississippi State Department | 0.553642 |
| Mississippi Medical Center | 0.792986 |
| novel synthetic cannabinoids | 0.694875 |
| UMMC emergency department | 0.57475 |
| different synthetic cannabinoids | 0.71116 |
| cannabinoid receptor | 0.604977 |
| general inpatient services | 0.536039 |
| systolic blood pressure | 0.539426 |
| Health Alert Network | 0.589169 |
| law enforcement officials | 0.528387 |
| synthetic cannabinoid intoxication | 0.804745 |
| physical examination findings | 0.532932 |
| Mississippi emergency departments | 0.584308 |
| health care providers | 0.701973 |
| UMMC patient population | 0.564496 |
| previous medical history | 0.550803 |
| synthetic cannabinoids | 0.97955 |
| Amelia M. Kasper | 0.567138 |
| National Center | 0.532197 |
| 3Georgia Poison Center | 0.548707 |
| vital signs | 0.544867 |
| urine drug | 0.545758 |
|
| Environmental Health | 0.541365 |
| chromatography-quadrupole time-of-flight mass | 0.543086 |
| Mississippi State Medical | 0.59541 |
| patients | 0.612676 |
| Justin K. Arnold | 0.552662 |
| public health officials | 0.5578 |
| San Francisco | 0.603391 |
| medical service reports | 0.568134 |
| urine drug screen | 0.53593 |
| Severe Illness Associated | 0.583807 |
| clinical urine drug | 0.539404 |
| Alison D. Ridpath | 0.561553 |
| California San Francisco | 0.537105 |
| plant-based opioid agonist | 0.538365 |
| Mississippi State Department | 0.985309 |
| Patrick B. Kyle | 0.557974 |
| Mississippi Poison Control | 0.591935 |
| 5Mississippi Poison Center | 0.548531 |
| intensive care admission | 0.538425 |
| main psychoactive component | 0.533303 |
| Environmental Biomonitoring Laboratory | 0.5557 |
| clinical laboratory data | 0.552737 |
| intensive care services | 0.547569 |
|
CLICK HERE |
| 14075 |
Centers for Disease Control and Prevention |
Html |
en |
HAN Archive - 00385|Health Alert Network (HAN) |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| ongoing transmission | 0.350118 |
| Zika virus | 0.953386 |
| areas | 0.350292 |
| CDC Health Advisory | 0.360303 |
| pregnant women | 0.429485 |
| state health departments | 0.429044 |
| World Health Organization | 0.358942 |
| -registered insect repellents | 0.342051 |
| dengue virus | 0.381349 |
| Zika virus disease | 0.612277 |
| fetal losses | 0.350751 |
| virus clinical disease | 0.412391 |
| Virus-specific neutralization testing | 0.345686 |
| possible congenital infection | 0.352946 |
| RT-PCR protocols | 0.350126 |
| Zika virus transmission | 0.502959 |
| laboratory-confirmed Zika virus | 0.412047 |
| maculopapular rash | 0.381214 |
| American Health Organization | 0.35861 |
| Zika virus laboratory | 0.424016 |
| Environmental Protection Agency | 0.342338 |
| healthcare providers | 0.481795 |
| CDC Health Alert | 0.365985 |
| United States | 0.395918 |
| Aedes species mosquitoes | 0.345535 |
|
| commercially available test | 0.343509 |
| Zika virus infection | 0.737514 |
| continental United States | 0.395386 |
| specific antiviral treatment | 0.343558 |
| local health department | 0.386855 |
| enhances health decisions | 0.346968 |
| local transmission | 0.466346 |
| critical health issues | 0.348395 |
| state health department | 0.354944 |
| yellow fever viruses | 0.344715 |
| acute onset | 0.379756 |
| current outbreak | 0.351829 |
| Zika virus infections | 0.526936 |
| virus disease cases | 0.490855 |
| chikungunya virus infection | 0.410895 |
| similar geographic distribution | 0.342599 |
| non-steroidal anti-inflammatory drugs | 0.343067 |
| bites | 0.334185 |
| Aedes albopictus mosquitoes | 0.350057 |
| laboratory diagnostic testing | 0.344266 |
| Zika virus IgM | 0.417592 |
| risk | 0.33966 |
| CDC Arbovirus Diagnostic | 0.350115 |
| Zika virus testing | 0.41686 |
|
CLICK HERE |